Skip to content

Hudson waterfront at W. 44th now has kayaking and stand up paddle-boarding available.


A can of tennis balls is now available to members at the Riverside clay courts. Good deal and excellent courts.

In this study, researchers investigated prompt impacts of a single cup of tea up to an hour post–consumption on self–reported valence, arousal, discrete emotions, and implicit measures of mood. More servings over a longer time may be required to evoke tea’s arousing effects and appropriate tea consumption settings may evoke more enduring valence effects.

A drug already approved to treat osteoporosis could also be used to prevent breast cancer due to BRCA1 mutation.

Obesity rates on the rise among women, teens in US

NBC Nightly News (6/7, story 9, 0:15, Holt) reported, “The CDC now says over 40 percent of women…and 35 percent of men” are obese. The CBS Evening News (6/7, story 7, 2:05, Pelley) reported, “Many experts say sugar is the enemy.”

In “Science Now,” the Los Angeles Times (6/7, Kaplan) reports, “One report finds that 35% of men and 40% of women were obese as of 2014, the most recent year for which data were available.” The other report indicates “that 17% of children and teens were obese as well, including nearly 6% who were morbidly obese.” Both reports were published in the Journal of the American Medical Association.

NBC News (6/7, Fox) reports on its website that these “reports…show that efforts to encourage Americans to lose weight – at least to stop putting on more weight – are having little effect.”

Results of a recent study suggest that the combination of two common diabetes drugs could reduce mortality and the risk of adverse cardiovascular events.

PPIs may be linked to an increased risk of CKD, study reveals

ABC World News Tonight (4/14, story 10, 0:25, Muir) reported that a study has linked “proton pump inhibitors including Nexium [esomeprazole magnesium] and Prilosec [omeprazole] to an increased risk of chronic kidney disease [CKD].”

According to CNN (4/14, Christensen), some “173,321 people who used PPIs and 20,270” who “took a PPI alternative known as histamine H2 receptor blockers” were included in the five-year study.

The CBS News (4/14, Welch) website reports that “over five years of follow-up…15 percent of people using PPIs were diagnosed with chronic kidney disease, versus 11 percent of those on H2-blockers,” which “translated to a 28 percent increased risk of developing kidney disease for PPI users.” While just “a few patients in the study – less than 0.2 percent – developed end-stage kidney failure..the risk was 96 percent higher for those on PPIs.” The study was published online in the Journal of the American Society of Nephrology.